Introduction
The discovery of a discrete pulmonary lesion on the chest radiograph demands a precise and rapid diagnosis in view of the ever-present risk of malignancy. Biopsy may be undertaken by means of the transbronchial route using the fibreoptic bronchoscope, via thoracotomy, or via a percutaneous transthoracic aimed approach using a wide choice of aspirating or cutting needles. One of these methods is usually invoked since sputum cytology and culture are relatively ineffective for obtaining a tissue diagnosis from this type of mass, particularly if it is situated in the outer two-thirds of the lung.
Percutaneous transpleural needle biopsy of the lung is not a new procedure. It has been practised over many years since its introduction in the last century by Leyden, who aspirated organisms causing a pneumonia' and then by Menetrier, who three years later diagnosed a bronchial carcinoma by needle aspiration. Subsequently, several large series have been reported, using either an aspirating or a cutting technique.3 Until recent years, percutaneous lung biopsy has not been as popular a procedure in the United Kingdom as in the United States and Scandinavia because of its complications. However, with the advent of aspiration biopsy using relatively narrow gauge needles, the procedure has become safer and now has a secure place in the diagnosis of isolated pulmonary lesions, many of which will be neoplastic. The biopsy is simply and rapidly performed, inexpensive, well tolerated by the patient, low in complications and readily repeated if necessary.
The incidence of a solitary pulmonary lesion on a chest radiograph is approximately 0.1%. 16 Since both benign lesions, such as granulomata, and malignant ones, including metastases and primary adenocarcinomas, are peripheral, bronchoscopic biopsy is not possible. To establish the benign nature of such a lesion saves the patient having a thoracotomy, whilst it is equally important to make the diagnosis of malignancy in a patient unfit or unsuitable for thoracotomy.
Of all solitary mass lesions seen on radiography in patients over 50 years, 30-50% will be carcinomata.7 Ethnic and geographical background, age, industrial exposure and smoking habits may suggest the nature of a lesion, but cannot allow a watertight diagnosis without tissues being obtained. A mass with localized rib destruction is likely to be malignant in nature, though not all nodules containing calcification will be benign. Granulomata and localized area of infection account for the majority of the non-malignant cases.8
Indications
The investigation of a mass lesion demonstrated on the chest radiograph, especially where it is peripherally situated and where sputum culture/cytology and bronchoscopy (if indicated) have failed to furnish a diagnosis ( Figure 1) . Either computed tomography (CT) or fluoroscopy guidance can be used. The latter is less timeconsuming and cumbersome and allows a 'realtime' approach. Biplane fluoroscopy of a 'C' arm ( Figure 2 ) is ideal though not mandatory, and certainly not essential for large lesions. CT is more appropriate for lesions that are invisible on a PA chest radiograph (or in those where a small lesion present on the chest radiograph cannot be identified and therefore cannot accurately be biopsied). Difficult areas to biopsy include lesions behind the sternum, related to chest wall ( Figure 3 ) or in the posterior costophrenic angle. It may also be used for lesions that are relatively inaccessible, i.e., adjacent to the scapula. Pleural lesions may be localized and biopsied using ultrasound or fluoroscopy9 ( Figure 4) .
In all patients, a radiograph should be taken on the day of the biopsy prior to the procedure to ensure that the lesion has not altered (or cleared) since the film performed days or weeks before.10 A pre-requisite for successful biopsy is the accurate measurement of the position of the lesion and its distance from the nearest skin surface. This distance is calculated from PA and lateral chest radiographs, plus, when necessary, either conventional or computed tomography (Figure lb) .
Prior to biopsy the patient is placed in either the prone or supine position (lateral or oblique being uncomfortable) and 10-20mg venously. Under fluoroscopy, a skin marker is placed over the lesion to be biopsied. Skin, chest wall and pleura are infiltrated with 5ml 1% lignocaine, and a needle selected for biopsy. Fine gauge (20-22 FG) needles are safest. Recommended are the 15cm long 20 gauge screw biopsy needles of Surgimed, A/S, Denmark ( Figure 5 ). The needle is advanced vertically towards the lesion in the AP plane. Next, the 'C' arm image intensifier is positioned for lateral screening and the needle advanced during lateral screening. Throughout this manoeuvre the patient breathes quietly, though is asked to breath-hold as the needle traverses the pleura.
Once the needle abuts the lesion, the stilette is removed and replaced by a screw attachment. This has the advantage of penetrating hard lesions (such as granulomata) providing abundant material for cytology and sometimes small tissue fragments for histology. An aspirating needle is also safer than a cutting if fluid is to be aspirated from a cavity.
14FG 'Trucut' (Travenol, UK) needles have been used, and provide good histological specimens. However, due to the increased risk of pulmonary haemorrhage and pneumothorax they should be reserved for peripheral, pleural based, or chest wall lesions. Recently a mechanically fired 18G Trucut has been introduced (Biopty M, Radiplast, Sweden) and provides excellent specimens with fewer complications than the large gauge needle.
It is important to make as few 'passes' as are necessary to make a confident diagnosis. Most cytologists are happy to attend the biopsy themselves or to send a cytotechnician so that slides may be smeared correctly and the radiologist assured that material appears to be present ( Figure 6 ). It is worthwhile waiting 15 minutes for the final cytological opinion to be rung through before removing the needle (or perhaps making a further biopsy) ( Figure 7 ). Certainly up to 3 passes may be made at any one sitting, particularly if the lesion is small and/or relatively inaccessible. Passes should ideally be at different sites within the lesion.
After the needle is withdrawn, the patient is screened in expiration for possible pneumothorax. Irrespective of its presence or absence, the postprocedural advice is for the patient to lie laterally for two hours, with the side of the biopsy lowermost, as this may help to seal any small air leak. After four hours a chest radiograph is taken on expiration. If a pneumothorax is not present, the patient may be discharged home. However, the presence of even a small pneumothorax means that the patient must remain in hospital overnight.
Complications
Pneumothorax is the commonest, and occurs in 15- is based upon the visualization of a pneumothorax on a post-biopsy chest film, and the incidence is almost certainly very much higher, since supine CT scans performed after a biopsy invariably show a small anterior pneumothorax (Allison, personal communication, 1987 
